Work

Abstract 6002: Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Results of a multicenter, phase II trial (TRAP)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6002

Authors: Jingdong Zhang, Qian Dong, Yuanhe Wang, Yanwen Diao, Xiujie Cui, Li Man, Jian Zhang, Yuyang Zhang, Tao Wu, Tiejun Chen, Yuyang Dong, Junwei Zhang, Yanyuan Huang, Siliang Wang

Institutions: Liaoning Cancer Hospital & Institute, China Medical University, Xinyang Central Hospital, Fuzhou University, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629987

Cites:

Cited by: 1

Related to: 10